Erasca (ERAS) Cash from Financing Activities (2020 - 2026)

Erasca (ERAS) posted Cash from Financing Activities of $244.7 million for Q1 2026, up 42450.26% on a QoQ basis from $575000.0 in Q4 2025, and up 741306.06% year-over-year from N/an in Q1 2025.

Erasca (ERAS) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Erasca's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $244.7 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 741306.06% year-over-year to $244.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $245.7 million (up 5.1% YoY) and the FY2025 annual result came in at $1.1 million, down 99.54% from the prior year.
  • Cash from Financing Activities was $244.7 million for Q1 2026 at Erasca, up from $575000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $244.7 million in Q1 2026 and bottomed at $7000.0 in Q3 2023.
  • A 5-year average of $34.5 million and a median of $575000.0 in 2025 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 99.87% — and 2026, when it surged 741306.06%.
  • Erasca's Cash from Financing Activities stood at $96.2 million in 2022, then slumped by 99.53% to $456000.0 in 2023, then soared by 75.66% to $801000.0 in 2024, then slipped by 28.21% to $575000.0 in 2025, then soared by 42450.26% to $244.7 million in 2026.
  • Business Quant data shows ERAS's Cash from Financing Activities at $244.7 million in Q1 2026, $575000.0 in Q4 2025, and $41000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Erasca 5.89 Bn 5.89 Bn - 244.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 244.66 Mn
Mar 31, 2026 244.66 Mn
Dec 31, 2025 575,000.00
Dec 31, 2025 575,000.00
Sep 30, 2025 41,000.00
Sep 30, 2025 41,000.00
Jun 30, 2025 447,000.00
Jun 30, 2025 447,000.00
Mar 31, 2025 33,000.00
Mar 31, 2025 33,000.00
Dec 31, 2024 801,000.00
Dec 31, 2024 801,000.00
Sep 30, 2024 21.10 Mn
Sep 30, 2024 21.10 Mn
Jun 30, 2024 211.87 Mn
Jun 30, 2024 211.87 Mn
Mar 31, 2024 6.93 Mn
Mar 31, 2024 6.93 Mn
Dec 31, 2023 456,000.00
Dec 31, 2023 456,000.00